Decentralized Clinical Trials Promised Faster Recruitment. The Evidence on Actual Performance Is In.
Dr. Dereck Mush, MD, MBA
Antidote
Connects patients with clinical trials through an accessible online search platform.
What they do
Antidote is a digital health company that utilizes structured data and natural language processing to simplify clinical trial matching. Their online search platform allows patients to easily find and enroll in appropriate clinical trials based on their medical history.
The record
- Vertical
- Clinical Trials
- Sub-segment
- Patient recruitment
- Product type
- Marketplace
- Stage
- Series B
- Headquarters
- London, United Kingdom
- Region
- Europe
- Founded
- 2010
- Total funding
- $44M raised
Notable investors: LRE Co-Invest, S3 Ventures, Octopus Ventures, WR Hambrecht.
Also in Clinical Trials
Related on The Signal
Dr. Dereck Mush, MD, MBA
Unlocking Orphan Neuromuscular Indications: Why IntraBio's Aqneursa Approval Signals a Regulatory Re-evaluation of Small-Cohort Crossover Trials
Dr. Dereck Mush, MD, MBA
Decentralized and adaptive trial designs move from pilot to default in biotech development plans
Dr. Dereck Mush, MD, MBA
Inside SURPASS: ARPA-H's Bid to Redesign Clinical Trials
Dr. Dereck Mush, MD, MBA